Cargando…
Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes
The pathogenesis of Coronavirus disease 2019 is still obscure and the need for exploration of possible mechanisms to suggest drugs based on knowledge should never be delayed. In this manuscript, we present a novel theory to explain the pathogenesis of COVID-19; lymphocyte distraction theory upon whi...
Autor principal: | Kelleni, Mina T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author. Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640889/ https://www.ncbi.nlm.nih.gov/pubmed/33197762 http://dx.doi.org/10.1016/j.biopha.2020.110982 |
Ejemplares similares
-
SARS CoV-2 viral load might not be the right predictor of COVID-19 mortality
por: Kelleni, Mina T.
Publicado: (2021) -
Non-steroidal anti-inflammatory drugs and bladder cancer prevention
por: Castelao, J E, et al.
Publicado: (2000) -
Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management
por: Kelleni, Mina T.
Publicado: (2020) -
NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown?
por: Kelleni, Mina T.
Publicado: (2021) -
Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
por: Klein, Amir, et al.
Publicado: (2010)